« Back to Record
Gigante, E., Hobeika, C., Le Bail, B., Paradis, V., Tougeron, D., Lequoy, M., Bouattour, M., Blanc, J. F., Ganne-Carrié, N., Tran, H., Hollande, C., Allaire, M., Amaddeo, G., Regnault, H., Vigneron, P., Ronot, M., Elkrief, L., Verset, G., Trepo, E., Zaanan, A., Ziol, M., Ningarhari, M., Calderaro, J., Edeline, J., & Nault, J. C. (2022). Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma. Liver Cancer, 11(5), 460-473. doi:10.1159/000525488
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/355823



